Skip to content

Clinical trials

Phase 2/3 Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2/3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20072
20083
20092
20101
20131
20141
20162
20192
20213
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated8
Recruiting4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC2
University of California, Los Angeles2
Acticor Biotech1
Boston Scientific Corporation1
DiaMedica Therapeutics Inc1
Joyce Chen1
Lower Merion Neurology Research Foundation1
Maimonides Medical Center1
Memorial Hermann Health System1
NMT Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke26
Ischemic Stroke10
Ischemic Attack, Transient4
Brain Injuries, Traumatic3
Aphasia2
Aphasia, Broca2
Brain Ischemia2
Hemiplegia2
Hemorrhagic Stroke2
Hypertension2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.